| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/01/2005 | US6849401 Methods for determining coat color genotypes in pigs |
| 02/01/2005 | US6849400 Methods for detecting and measuring spliced nucleic acids |
| 02/01/2005 | US6849398 For detecting cleavage or ligation reactions; particularly, invention relates to assays which employ substrates covalently linked both to solid phase matrix and to nucleotide strand encoded to identify substrate; includes pcr primer sequences |
| 02/01/2005 | US6849397 Classifying organism; obtain sample, incubate with surface plasmon resonance substrate, analyze nucleotide sequences immobilized on the substrate, classify |
| 02/01/2005 | US6849395 Gene cluster screening of clones having DNA from mixed populations of organisms |
| 02/01/2005 | US6849261 CD4-independent HIV envelope proteins as vaccines and therapeutics |
| 02/01/2005 | CA2436349A1 The selective mmp-9-inhibitor rega-3g12scfv ameliorates in vivo parameters of kidney function after renal ischemia |
| 02/01/2005 | CA2325351C Non-stochastic generation of genetic vaccines and enzymes |
| 02/01/2005 | CA2302067C Method and devices for performing analysis of nucleic acid sample |
| 02/01/2005 | CA2270166C Method for determining the catalytic activity of factor ixa |
| 02/01/2005 | CA2094261C Polypeptide of a growth factor receptor family, application in the diagnosis and treatment of myeloproliferative diseases |
| 01/29/2005 | CA2445420A1 Kinase and phosphatase assays |
| 01/28/2005 | CA2469094A1 Methods for diagnosis and therapy of cancer and composition useful therein |
| 01/27/2005 | WO2005008450A2 Method and apparatus for nanogap device and array |
| 01/27/2005 | WO2005008252A2 Methods and compositions for assaying homocysteine |
| 01/27/2005 | WO2005008251A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis |
| 01/27/2005 | WO2005008250A1 Compounds and methods for promoting angiogenesis by using a gamma-secretase inhibitor or inhibiting the gamma-secretase pathway |
| 01/27/2005 | WO2005008248A2 Diagnosis and treatment of cervical cancer |
| 01/27/2005 | WO2005008239A1 Lentivirus assay system including vif protein activity |
| 01/27/2005 | WO2005008213A2 Expression profile algorithm and test for cancer prognosis |
| 01/27/2005 | WO2005007896A1 Methods for identifying modulators of quorum-sensing signaling in bacteria |
| 01/27/2005 | WO2005007895A1 Methods and kits for obtaining nucleic acid from biological samples |
| 01/27/2005 | WO2005007894A1 Pyrosequencingtm of rna editing isoforms |
| 01/27/2005 | WO2005007893A2 Universal detection of binding |
| 01/27/2005 | WO2005007892A1 Methods and systems for diagnosis of non-cenral nervous system (cns) diseases in cns samples |
| 01/27/2005 | WO2005007891A2 Variants of human taste receptor genes |
| 01/27/2005 | WO2005007890A2 Means and methods for detecting a risk of infarction related to atherosclerosis |
| 01/27/2005 | WO2005007889A1 Method for diagnosing colorectal cancers |
| 01/27/2005 | WO2005007888A1 Reporter gene assay, kit therefor and culture medium |
| 01/27/2005 | WO2005007887A1 Measurement of a polynucleotide amplification reaction |
| 01/27/2005 | WO2005007886A2 Method for displaying and selecting a protease molecule |
| 01/27/2005 | WO2005007885A1 Improvements in and relating to the analysis of dna |
| 01/27/2005 | WO2005007884A1 Use of ethilene oxide to provide dna dree items |
| 01/27/2005 | WO2005007883A2 Method for detecting and/or identifying bacteria of genus staphylococcus |
| 01/27/2005 | WO2005007882A2 Sample preparing unit |
| 01/27/2005 | WO2005007881A2 Improving production characteristics of cattle |
| 01/27/2005 | WO2005007880A1 Pknb kinase and pstp phosphatase and methods of identifying inhibitory substances |
| 01/27/2005 | WO2005007879A1 In vivo calibration method for subcutaneous amperometric glucose sensors and system therefor |
| 01/27/2005 | WO2005007875A2 Enhanced promoters for synthesis of small hairpin rna |
| 01/27/2005 | WO2005007874A2 Sequential generation of multiple chemiluminescent signals on solid supports |
| 01/27/2005 | WO2005007872A2 Detection of a target in a preservative solution |
| 01/27/2005 | WO2005007871A2 Genetic marker of response to atypical antipsychotics and antidepressants and methods for use thereof |
| 01/27/2005 | WO2005007869A2 Assays for the direct measurement of gene dosage |
| 01/27/2005 | WO2005007868A2 Controlled platelet activation to monitor therapy of adp antagonists |
| 01/27/2005 | WO2005007852A2 Room temperature elution of nucleic acids |
| 01/27/2005 | WO2005007849A1 Method of enhancing alkylating drug sensitivity |
| 01/27/2005 | WO2005007844A1 Method of screening for agents that modulate immunophilin/peptidylproline cis-trans isomerase (ppiase)-homer interaction |
| 01/27/2005 | WO2005007830A2 Methods and compositions for diagnosis, staging and prognosis of prostate cancer |
| 01/27/2005 | WO2005007825A2 Modulation of aminopeptidase n expression |
| 01/27/2005 | WO2005007823A2 Compositions, kits, and methods for stimulation of homologous recombination |
| 01/27/2005 | WO2005007822A2 Method for assaying protein-protein interaction |
| 01/27/2005 | WO2005007816A2 Compositions and methods for identifying an individual organism based on single nucleotide polymorphisms |
| 01/27/2005 | WO2005007815A2 Hairpin-labeled probes and methods of use |
| 01/27/2005 | WO2005007814A2 Genome mapping of functional dna elements and cellular proteins |
| 01/27/2005 | WO2005007812A2 Genes as diagnostic tools for autism |
| 01/27/2005 | WO2005007677A2 Affinity capture of peptides by microarray and related methods |
| 01/27/2005 | WO2005007663A2 Fluorogenic enzyme substrates and uses thereof |
| 01/27/2005 | WO2005007623A2 Inhibition of syk kinase expression |
| 01/27/2005 | WO2005007282A2 Storage and use of colloids |
| 01/27/2005 | WO2005007279A2 Compounds for changing the physical properties of ice and methods of use thereof |
| 01/27/2005 | WO2005007144A2 Method of diagnosis and treatment for asthma based on haplotype association |
| 01/27/2005 | WO2005007119A2 Assays for protease enzyme activity |
| 01/27/2005 | WO2005007097A2 Breast cancer genes |
| 01/27/2005 | WO2005006971A2 Method for assessing behavioral predisposition |
| 01/27/2005 | WO2005006960A2 Detection of cell membrane-associated proteins using membrane fragments displayed on encoded microparticle arrays |
| 01/27/2005 | WO2005006951A2 Methods and compositions for determining whether a subject carries a cystic fibrosis transmembrane conductance regulator (cftr) gene mutation |
| 01/27/2005 | WO2005006940A2 Detection of mutations in nucleic acid sequences |
| 01/27/2005 | WO2004109279A3 Sensitive and selective in vitro assay for the detection of reactive drug intermediates |
| 01/27/2005 | WO2004104575A3 Diagnostics and therapeutics for diseases associated with x-prolyl aminopeptidase 2 (xpnpep2) |
| 01/27/2005 | WO2004101822A3 Use of bage (b melanoma antigens) loci as tumour markers |
| 01/27/2005 | WO2004099444A3 Diagnostic methods |
| 01/27/2005 | WO2004099442A3 Kcnma1 as a therapeutic target in cancer treatment |
| 01/27/2005 | WO2004091481A3 Methods and kits for detecting cerebrospinal fluid in a sample |
| 01/27/2005 | WO2004087954A3 Cell cycle related markers |
| 01/27/2005 | WO2004087942A3 Method for detecting escherichia coli |
| 01/27/2005 | WO2004087046A3 TREATMENT OR PREVENTION OF cGMP-DEPENDENT PATHOPHYSIOLOGY WITH A MUTANT VARIANT OF SOLUBLE GUANYLYL CYCLASE |
| 01/27/2005 | WO2004082575A3 Diagnostics and therapeutics for diseases associated with phosphodiesterase 6b (pde6b) |
| 01/27/2005 | WO2004081534A3 Phosphokinase assay |
| 01/27/2005 | WO2004081530A3 Method and apparatus for environmental monitoring and bioprospecting |
| 01/27/2005 | WO2004074514A3 Method of diagnosis of type 2 diabetes and early onset thereof |
| 01/27/2005 | WO2004074325A3 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers |
| 01/27/2005 | WO2004072232A3 Covalent tethering of functional groups to proteins |
| 01/27/2005 | WO2004063352A3 Methods and compositions for optical detection of single-stranded polynucleotides |
| 01/27/2005 | WO2004060053A3 Transgenic mice expressing human cd20 |
| 01/27/2005 | WO2004052300A3 Modulation of alpha-methylacyl-coa racemase expression |
| 01/27/2005 | WO2004051224A3 Multiplexed methylation detection methods |
| 01/27/2005 | WO2004025254B1 Food-borne pathogen and spoilage detection device and method |
| 01/27/2005 | WO2003102216A3 Multiplexed systems for nucleic acid sequencing |
| 01/27/2005 | WO2003101377A3 Association of snps in the dgcr2 locus and neighboring loci with schizophrenia |
| 01/27/2005 | WO2003054211A3 Receptors for hypersensitive response elicitors and uses thereof |
| 01/27/2005 | WO2003031594A3 Nucleotide and amino acid sequences relating to respiratory diseases and obesity |
| 01/27/2005 | WO2003027633A3 Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles |
| 01/27/2005 | WO2002087554B1 Ef-tu binding agent as antibacterial agent |
| 01/27/2005 | WO2002042417A3 Human erg2 potassium channel |
| 01/27/2005 | US20050021240 Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen based on the methylation status of the DNA |
| 01/27/2005 | US20050020937 Method for detecting pathogenic agents |
| 01/27/2005 | US20050020826 Mixing a pyrimidine derivative having a specific base sequence with a sample suspected of containing a target nucleic acid having a base sequence that is complementary or complementary to the compound's base sequence to form a complex, |
| 01/27/2005 | US20050020547 Compounds for the treatment of female sexual dysfunction |
| 01/27/2005 | US20050020526 Oligodeoxynucleotide intervention for prevention and treatment of sepsis |
| 01/27/2005 | US20050020519 Increase concentration of peptide; controlling glucose uptake into cells; adjust metabolism; stimulate cell proliferation; reduce apoptosis; moderate gene expression' |